REG - Craneware plc - Proposed Reduction of Capital

CranewareAnnouncement

01/08/2025 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250801:nRSA7023Ta&default-theme=true

RNS Number : 7023T  Craneware plc  01 August 2025

Craneware plc

("Craneware" or the "Company")

 Proposed Reduction of Capital and Notice of General Meeting

 

1 August 2025 - Craneware (AIM: CRW.L), a leader in healthcare financial
performance solutions, announces that it has today posted a circular to
shareholders (the "Circular"), incorporating a Notice of General Meeting (the
"General Meeting"), regarding a proposed reduction of capital. The General
Meeting will be held at 3 p.m. on 20 August 2025 at the offices of Craneware
plc, Tanfield House, 1 Tanfield, Edinburgh, EH3 5DA, UK.

The proposed reduction of capital, if approved, would create distributable
reserves that would give the Company further flexibility to deliver
shareholder returns over the coming years either in the form of distributions
and/or purchases of the Company's own shares.

The reduction of capital process comprises: (i) the proposed cancellation of
the entire amount standing to the credit of the Company's share premium
account (the "Share Premium Reduction"); and (ii) the proposed capitalisation
of the entire amount standing to the credit of the Company's merger reserve by
issuing B Ordinary Shares in the capital of the Company and the subsequent
cancellation of such B Ordinary Shares (the "Merger Reserve Reduction"). The
Share Premium Reduction and the Merger Reserve Reduction together comprise the
"Reduction of Capital".

The Reduction of Capital is conditional upon the passing by the Company's
shareholders of the resolutions set out in the Notice of General Meeting, as
well as confirmation being obtained from the Court of Session, Edinburgh,
Scotland (the "Court").

The Reduction of Capital, if approved by shareholders and confirmed by the
Court, is expected to create additional distributable reserves of US$
284,185,184.18. The Reduction of Capital itself will not involve any
distribution or repayment of capital, share premium or merger reserve by the
Company and will not reduce the underlying net assets of the Company.

The Circular (including the Notice of General Meeting) will shortly be
available for viewing on the Company's website at www.thecranewaregroup.com

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 

 Publication of the Circular                                                    1 August 2025

 Latest time and date for receipt of Forms of Proxy                             3 p.m. on 18 August 2025

 General Meeting                                                                3 p.m. on 20 August 2025

 Expected date of the first Court hearing for initial directions                in or around late August 2025

 Capital Reduction Record Time                                                  6.30 p.m. on the Business Day

                                                                                preceding the Court hearing to confirm the Reduction of Capital
 Expected date of the second Court hearing to confirm the Reduction of Capital  in or around October 2025

 Effective Date of the Reduction of Capital                                     Business Day after the Court order

                                                                                confirming the Reduction of Capital

 

Notes: Each of the times and dates, as set out in the Expected Timetable of
Principal Events above, is based on current expectations and is subject to
change. If any of the above times and/or dates is changed, the revised times
and/or dates will be notified to Shareholders by announcement through a
regulatory information service. All above references to times are to London
times.

For further information, please contact:

 

 Craneware plc                                     +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma Strategic Communications (Financial PR)      +44 (0)20 3405 0205
 Caroline Forde, Kinvara Verdon, Sarah Peters      craneware@almastrategic.com

 Peel Hunt (NOMAD and Joint Broker)                +44 (0)20 7418 8900
 Neil Patel, Benjamin Cryer, Kate Bannatyne

 Investec Bank PLC (Joint Broker)                  +44 (0)20 7597 5970
 Patrick Robb, Virginia Bull, James Smith
 ( )                                               ( )
 Berenberg (Joint Broker)                          +44 (0)20 3207 7800
 Mark Whitmore, Richard Andrews, Patrick Dolaghan

 

About The Craneware Group

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus(®) cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth.

As a trusted Microsoft partner, we provide future-ready solutions-including
the Best in KLAS Trisus Chargemaster-that simplify the complexities of
healthcare finance and operations. What sets us apart is our unique
combination of deep healthcare expertise and engineering excellence,
positioning us as a strategic partner rather than just a technology provider.

The Craneware Group empowers healthcare organizations to achieve sustainable
financial success while delivering better outcomes for the communities they
serve-today and in the future. Together, we are transforming the business of
healthcare.

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSSDFIFEISEDA